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Abstract 
Background: The aim of this study was to explore epilepsy-related mechanism so as to figure out the possible tar-
gets for epilepsy treatment.
Methods: The gene expression profile dataset GES32534 was downloaded from Gene Expression Omnibus database. 
We identified the differentially expressed genes (DEGs) by Affy package. Then the DEGs were used to perform gene 
ontology (GO) and pathway enrichment analyses. Furthermore, a protein–protein interaction (PPI) network was con-
structed with the DEGs followed by co-expression modules construction and analysis.
Results: Total 420 DEGs were screened out, including 214 up-regulated and 206 down-regulated genes. Functional 
enrichment analysis revealed that down-regulated genes were mainly involved in the process of immunity regulation 
and biological repairing process while up-regulated genes were closely related to transporter activity. PPI network 
analysis showed the top ten genes with high degrees were all down-regulated, among which FN1 had the highest 
degree. The up-regulated and down-regulated DEGs in the PPI network generated two obvious sub-co-expression 
modules, respectively. In up-co-expression module, SCN3B (sodium channel, voltage gated, type III beta subunit) was 
enriched in GO:0006814 ~ sodium ion transport. In down-co-expression module, C1QB (complement C1s), C1S (com-
plement component 1, S subcomponent) and CFI (complement factor I) were enriched in GO:0006955 ~ immune 
response.
Conclusion: The immune response and complement system play a major role in the pathogenesis of epilepsy. Addi-
tionally, C1QB, C1S, CFI, SCN3B and FN1 may be potential therapeutic targets for epilepsy.
Keywords: Epilepsy, Differentially expressed genes, Functional annotation, Protein–protein interaction network, 
Co-expression module
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Background
Epilepsy characterized by epileptic seizures, is a kind 
of neurological disorder [1]. Epileptic seizure is defined 
as “a state produced by an abnormal excessive neuronal 
discharge within the central nervous system” in terms 
of the mechanism. Seizure may originate from any part 
of the brain and spread to other areas [2]. It has been 
reported that there are approximately one million peo-
ple diagnosed with seizure or epilepsy in an emergency 
department annually in the United States [3]. Patients 
with epilepsy or seizure often present decreased level of 
consciousness and disorder to response to environment. 
Therefore, better understanding of the mechanisms 
underlying alteration of consciousness in epilepsy is 
important for the treatment of patients with epilepsy [4].
Currently, the pathogenesis of epilepsy has been 
widely investigated. Epilepsy may develop from the up-
regulated excitatory circuits or down-regulated excita-
tory due to brain injury [5]. A previous study indicated 
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that a loss of glutamine synthetase was the direct fac-
tor for high level of extracellular glutamate that played 
a key role in the occurrence of epileptic seizures [6]. 
Turrin et  al. [7] suggested a different mechanism 
related with pro-inflammatory expression in regulat-
ing the innate immune reaction in response to seizures, 
which gave a new perspective for epilepsy related neu-
ropathology. Furthermore, it is reported that specific 
inflammatory pathways are chronically activated dur-
ing epileptogenesis and persist in chronic epileptic 
tissue, suggesting they may contribute to the etiopatho-
genesis of temporal lobe epilepsy [8]. However, current 
studies for genetic mechanism underlying epilepsy has 
not been clearly defined. Besides, there are not enough 
epilepsy related candidate genes which can be used as 
treatment targets.
In the present study, we investigated the global gene 
expression profile GSE32534, which was supplied by 
Niesen et  al. [9]. Additionally, He et  al. [10] used this 
expression profile to perform gene set enrichment analy-
sis and identified several epilepsy related transcription 
factors and pathways. However, they did not analyze 
the protein–protein interaction (PPI) network and co-
expression modules associated with epilepsy. PPI and 
co-expression modules analyses can provide new insights 
into protein function, besides, they may help to uncover 
the generic organization principles of functional cel-
lular networks [11]. Therefore, based on the dataset of 
GSE32534, we firstly identified the differentially expressed 
genes (DEGs) between healthy and epilepsy specimens. 
Then, gene ontology (GO) function and Kyoto encyclope-
dia of genes and genomes (KEGG) pathway analyses were 
performed on the selected DEGs to explore the biological 
roles of these DEGs. Finally, we constructed and analyzed 
PPI network and co-expression modules. We aimed to 
further explore the molecular mechanism underlying epi-
lepsy and explore novel gene targets for epilepsy therapy.
Methods
Data pre‑processing and differentially expressed gene 
analysis
The epilepsy related dataset (accession number: 
GSE32534) that was contributed by Niesen et al. [9] was 
downloaded from the Gene Expression Omnibus (GEO, 
http://www.ncbi.nlm.nih.gov/geo/) based on Affym-
etrix Rat Genome U34 Array (Affymetrix Inc., Santa 
Clara, CA, USA). Data from ten peritumoral cortex tis-
sue specimens were available for further analysis, includ-
ing five samples from epilepsy and five from non-epilepsy 
patients with low grade brain tumor.
The probe-level data were converted into expres-
sion matrix by RMA (function in Affy package) in R 
language. Probe numbers were converted into gene 
names using Bioconductor annotation function in R 
language combined with annotation information in 
microarray platform GPL570 (HG-U133_Plus_2). The 
expression values of multiple probes for a given gene 
were reduced to a single value by taking the average 
expression value. After the expression data were nor-
malized [12], the DEGs (epilepsy vs. non-epilepsy) 
were identified by Limma package [13] in R language. 
Genes with |log2FC (fold change)| > 1 and p < 0.05 were 
defined as DEGs.
Functional enrichment analysis
Database for annotation, visualization, and integrated 
discovery (DAVID, http://david.abcc.ncifcrf.gov/) [14, 
15], an online tool, consists of an integrated biological 
knowledgebase and analytic tools aimed at systematically 
extracting biological meaning from large gene or protein 
lists [16]. In this study, the GO functional and KEGG 
pathway enrichment analyses for the screened DEGs was 
performed by DAVID. The multiple testing correction 
was performed using Benjamini–Hochberg (HB) method 
[17], and fold discovery rate (FDR) <0.05 was chosen as 
the cut-off criterion.
Construction of protein–protein interaction network
Search tool for the retrieval of interacting genes/pro-
teins (STRING, http://string-db.org/) [18] was used to 
construct protein–protein interaction network among 
DEGs. Genes with correlation coefficient higher than 
0.7 were mapped to PPI network, which was visualized 
by Cytoscape (http://www.cytoscape.org/) [19]. Igraph 
package in R language was used to calculate the connec-
tivity degree of each node.
Construction of co‑expression module
Expression similarity coefficient was calculated to select 
co-expression genes among DEGs. The co-expression 
module was constructed by the DEGs with expression 
similarity coefficient >0.99 and p < 0.001. GO and KEGG 
pathway enrichment analyses were performed for modu-
lar genes using the DAVID online tool.
Results
DEGs identification
After preprocessing, we obtained the expression values 
of 19,944 genes. The normalization showed a good result 
on a wide variety of array (Fig. 1). Total 420 DEGs were 
screened out, including 214 up-regulated and 206 down-
regulated genes. Hierarchical clustering indicated that 
the DEGs could clearly distinguish epilepsy samples from 
the normal controls (Fig. 2).
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GO functional and KEGG pathway enrichment 
analyses
The results of GO and KEGG enrichment analyses were 
displayed in Table 1. The significantly enriched GO terms 
of up-regulated DEGs were closely associated with cell–
cell signaling, synaptic transmission and transmission 
of nerve impulse. The down-regulated DEGs were sig-
nificantly enriched in immunity regulation and repair-
ing process of injured tissues. The significant pathway 
that enriched by up- and down-regulated DEGs was 
hsa04720:Long-term potentiation and hsa04510:Focal 
adhesion, respectively.
PPI network analysis
In the PPI network, rare interactions were observed 
between the up- and the down-regulated genes, while 
most interactions were observed within the up-regulated 
genes or the down-regulated genes (Fig. 3). Besides, nodes 
degree was analyzed for genes in PPI network to obtain 
the information of hub nodes. Ten DEGs were considered 
as hub genes, such as FN1 (fibronectin 1), COL1A2 (colla-
gen alpha-2), and C1QB (complement C1s) (Table 2).
Co‑expression modules
The co-expression modules were constructed with up- 
and down-regulated genes, respectively (Fig.  4). As 
shown in Table 3, obviously enriched GO terms of genes 
in up-co-expression module were GO:0006814 ~ sodium 
ion transport, GO:0030695  ~  GTPase regulator activity 
and GO:0060589  ~  nucleoside-triphosphatase regula-
tor activity. The down-regulated genes in the co-expres-
sion modules were mainly associated with immunity 
regulation and cell damage repairing processes. For 
instance, SCN3B (sodium channel, voltage gated, type 
III beta subunit) was enriched in GO:0006814 ~ sodium 
ion transport. C1QB, C1S (complement component 
1, S subcomponent), and CFI (complement factor I) 
were enriched in GO:0006955  ~  immune response and 
GO:0050778 ~ positive regulation of immune response.
Discussion
Epilepsy is defined as a chronic brain disorder and its 
genetic mechanism has not been elucidated clearly, 
which hampered the development of novel preventive 
and treatment management. In this study, we explored 
the molecular mechanism of human epilepsy by using 
bioinformatics methods and attempted to give a new 
insight to the design of good therapy. Total 214 up-reg-
ulated genes and 206 down-regulated DEGs between 
epilepsy and control group were screened out. Accord-
ing to PPI network analysis, top ten DEGs with high node 
degrees were all down-regulated. Among them, FN1 
showed the highest degree, which was closely associated 
with cell transport activity.
The data of GO analysis showed that the down-reg-
ulated DEGs in epilepsy patients were significantly 
Fig. 1 Box plot of expression data before and after normalization. The horizontal axis stands for different samples, while the vertical axis represents 
expression value. The black line in the box represents the expression median for each sample. a Data before normalization. b Data after normaliza-
tion. After preprocessing, the black lines of box plot are almost on the same straight line, indicating a high level of normalization
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enriched in immune response and defense response 
related biological processes. Recent evidence has sug-
gested that the innate and adaptive immune reaction 
is involved in the epilepsy, which was implicated in the 
inflammatory processes within the brain [20]. It has been 
proved that the immune system and the nervous system 
maintain extensive communication [21]. The inflam-
mation of brain contributed to the local neuronal excit-
ability that resulted in seizures [22]. Importantly, several 
inflammatory mediators, including temporal lobe epi-
lepsy and cortical dysplasia-related epilepsy, have been 
detected in surgically resected brain tissue from epilepsy 
patients [23]. Our results further supported that immune 
response and inflammatory processes might constitute a 
crucial mechanism in the pathophysiology of epilepsy.
Specially, in our study, several DEGs were found sig-
nificantly enriched in immune regulation related terms in 
the co-expression module, which was consistent with the 
Fig. 2 Cluster analysis of the differentially expressed genes. Each row represents a single gene and each column a single sample. The data are 
colored red for high abundance/up-regulation and green for low abundance/down-regulation
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results of GO functional analysis. These DEGs included 
C1QB, C1S, CFI, PTPRC, HLA-DRA and B2M. Previ-
ous study has found that the complement system rep-
resents an essential effector of both humoral immunity 
and cellular immunity [24]. Among these DEGs in the 
co-expression module, C1QB and C1S encoded the subu-
nits of human complement component C1 and play roles 
in the complement activation pathway. C1 deficiency and 
impaired activation of the complement classical pathway 
generally leads to severe immune complex disease [25]. 
Table 1 GO and KEGG pathway enrichment analysis for identified DEGs
Count represents the gene number
Category Term Count p value
Up-regulated genes
GOTERM_BP_FAT GO:0050877 ~ neurological system process 26 2.15E−04
GOTERM_BP_FAT GO:0019226 ~ transmission of nerve impulse 22 2.01E−11
GOTERM_BP_FAT GO:0006811 ~ ion transport 21 4.75E−05
GOTERM_BP_FAT GO:0007267 ~ cell–cell signaling 20 4.97E−06
GOTERM_BP_FAT GO:0007268 ~ synaptic transmission 19 5.63E−10
GOTERM_CC_FAT GO:0031224 ~ intrinsic to membrane 70 0.007687949
GOTERM_CC_FAT GO:0016021 ~ integral to membrane 65 0.030340215
GOTERM_CC_FAT GO:0005886 ~ plasma membrane 63 4.81E−06
GOTERM_CC_FAT GO:0044459 ~ plasma membrane part 48 9.49E−08
GOTERM_CC_FAT GO:0005887 ~ integral to plasma membrane 23 0.00337979
GOTERM_MF_FAT GO:0005216 ~ ion channel activity 15 1.16E−05
GOTERM_MF_FAT GO:0022838 ~ substrate specific channel activity 15 1.63E−05
GOTERM_MF_FAT GO:0015267 ~ channel activity 15 2.40E−05
GOTERM_MF_FAT GO:0022803 ~ passive transmembrane transporter activity 15 2.46E−05
GOTERM_MF_FAT GO:0022836 ~ gated channel activity 13 2.69E−05
KEGG_PATHWAY hsa04720:Long-term potentiation 7 1.89E−05
KEGG_PATHWAY hsa05014:Amyotrophic lateral sclerosis (ALS) 5 9.61E−04
KEGG_PATHWAY hsa04020:Calcium signaling pathway 7 0.003316868
KEGG_PATHWAY hsa04080:Neuroactive ligand-receptor interaction 8 0.005123351
KEGG_PATHWAY hsa04310:Wnt signaling pathway 5 0.037620947
Down-regulated genes
GOTERM_BP_FAT GO:0006955 ~ immune response 40 1.23E−16
GOTERM_BP_FAT GO:0006952 ~ defense response 30 1.65E−10
GOTERM_BP_FAT GO:0009611 ~ response to wounding 26 3.53E−09
GOTERM_BP_FAT GO:0007155 ~ cell adhesion 26 7.74E−07
GOTERM_BP_FAT GO:0022610 ~ biological adhesion 26 7.94E−07
GOTERM_MF_FAT GO:0005198 ~ structural molecule activity 20 4.49E−05
GOTERM_MF_FAT GO:0005509 ~ calcium ion binding 18 0.018905046
GOTERM_MF_FAT GO:0005201 ~ extracellular matrix structural constituent 13 1.09E−10
GOTERM_MF_FAT GO:0042802 ~ identical protein binding 13 0.041784269
GOTERM_MF_FAT GO:0004857 ~ enzyme inhibitor activity 12 1.53E−04
GOTERM_CC_FAT GO:0005576 ~ extracellular region 70 4.18E−15
GOTERM_CC_FAT GO:0005886 ~ plasma membrane 69 0.002166744
GOTERM_CC_FAT GO:0044421 ~ extracellular region part 50 4.52E−17
GOTERM_CC_FAT GO:0005615 ~ extracellular space 30 2.56E−08
GOTERM_CC_FAT GO:0005578 ~ proteinaceous extracellular matrix 28 1.34E−14
KEGG_PATHWAY hsa04510:Focal adhesion 16 4.33E−07
KEGG_PATHWAY hsa05322:Systemic lupus erythematosus 14 3.27E−09
KEGG_PATHWAY hsa04610:Complement and coagulation cascades 13 4.92E−10
KEGG_PATHWAY hsa04512:ECM-receptor interaction 13 5.21E−09
KEGG_PATHWAY hsa04060:Cytokine–cytokine receptor interaction 10 0.02253563
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C1QB has been found to be a epilepsy related gene and 
the expression of C1QB mRNA declines in brain peritu-
moral tissues of patients with tumor-induced epilepsy 
[26]. Besides, expression of various complement com-
ponents, such as C1q, C3c, and C3d, has been observed 
in reactive astrocytes within the sclerotic hippocampus 
of people with temporal lobe epilepsy [27]. Interest-
ingly, protein encoded by CFI is essential for regulating 
the complement cascade. CFI can inhibit the activation 
of complements by the inactivation of C3b and C4b and 
the normal combination of C3 and C5. The persistence 
of complement activation could contribute to a sustained 
inflammatory response and could destabilize neuronal 
networks [24]. Thus, the down-regulation of CFI may 
promote the activation of complements to accelerate the 
progression of epilepsy. Importantly, CFI has significant 
interconnectivity with C1S in this paper. Besides, CFI, 
C1S and C1QB jointly enriched in the complement acti-
vation pathway according to the results of GO and path-
way enrichment analysis. Taken together, we proposed 
that complement system might play key roles in the 
development of epilepsy by dysregulating the expression 
of C1QB, C1S and CFI.
In addition to down-co-expression module, in the up-
co-expression module, SCN3B was found enriched in 
GO terms related to sodium ion transport. The rapid and 
selective transport of sodium ion through sodium chan-
nels is essential for initiating action potentials within 
excitable cells [28]. Study has found that changes in the 
function of many ion channels, including sodium chan-
nels, contribute to the epileptogenesis [29]. Baek et  al. 
[30] reported that voltage-gated sodium channels could 
Fig. 3 PPI network. Green nodes represent down-regulated genes while red nodes represent up-regulated genes. The size of the nodes is positively 
correlated with the degrees of genes. The thickness of line is determined by the correlation coefficient provided by STRING
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Fig. 4 Co-expression module. Green nodes represent down-regulated genes while red nodes represent up-regulated genes
Table 3 GO functional and KEGG pathway enrichment analysis on genes in co‑expression modules
Count represents the gene number
ID Term Description Count p value
Up-co-expression GOTERM_BP_FAT GO:0016310 ~ phosphorylation 5 0.023081277
GOTERM_BP_FAT GO:0006793 ~ phosphorus metabolic process 5 0.043264378
GOTERM_BP_FAT GO:0006796 ~ phosphate metabolic process 5 0.043264378
GOTERM_BP_FAT GO:0006915 ~ apoptosis 4 0.049975204
GOTERM_BP_FAT GO:0006814 ~ sodium ion transport 3 0.014081453
GOTERM_CC_FAT GO:0005886 ~ plasma membrane 11 0.02927495
GOTERM_CC_FAT GO:0044459 ~ plasma membrane part 8 0.033090626
GOTERM_MF_FAT GO:0030695 ~ GTPase regulator activity 4 0.020009788
GOTERM_MF_FAT GO:0060589 ~ nucleoside-triphosphatase regulator activity 4 0.021203692
GOTERM_MF_FAT GO:0008289 ~ lipid binding 4 0.02652355
GOTERM_MF_FAT GO:0031402 ~ sodium ion binding 3 0.012457524
GOTERM_MF_FAT GO:0005543 ~ phospholipid binding 3 0.027145214
Down-co-expression GOTERM_BP_FAT GO:0006955 ~ immune response 9 1.01E−07
GOTERM_BP_FAT GO:0050778 ~ positive regulation of immune response 6 2.45E−07
GOTERM_BP_FAT GO:0048584 ~ positive regulation of response to stimulus 6 2.73E−06
GOTERM_BP_FAT GO:0002684 ~ positive regulation of immune system process 6 2.84E−06
GOTERM_BP_FAT GO:0006952 ~ defense response 6 2.72E−04
GOTERM_MF_FAT GO:0048154 ~ S100 beta binding 2 0.003999687
GOTERM_MF_FAT GO:0048306 ~ calcium-dependent protein binding 2 0.031586688
GOTERM_MF_FAT GO:0042803 ~ protein homodimerization activity 3 0.042687029
GOTERM_MF_FAT GO:0004175 ~ endopeptidase activity 3 0.052602322
GOTERM_MF_FAT GO:0005509 ~ calcium ion binding 4 0.05926993
GOTERM_CC_FAT GO:0005576 ~ extracellular region 7 0.020898219
KEGG_PATHWAY hsa04610:Complement and coagulation cascades 3 0.003647135
KEGG_PATHWAY hsa04612:Antigen processing and presentation 3 0.005241774
KEGG_PATHWAY hsa05322:Systemic lupus erythematosus 3 0.007393725
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initiate action potentials in brain neurons, and muta-
tion of the channels was associated with several forms 
of inherited epilepsy. Importantly, SCN3B, an enriched 
DEGs of this term, is demonstrated to encode voltage-
gated sodium channels. In adult brain, there are four 
accessory β subunits, including SCN1B, SCN2B, SCN3B 
and SCN4B. The β subunits are thought to affect traf-
ficking and gating of the voltage-gated sodium channels 
[31]. Therefore, we speculated that SCN3B might play 
an important role in the progression of epilepsy through 
sodium channels.
Furthermore, in our study, FN1 was found to have the 
highest degree in PPI network. FN1 is a multifunctional, 
extracellular matrix glycoprotein which contains several 
distinct domains that may bind to cell surfaces. Fibronec-
tin has been reported to play a role in cellular morphol-
ogy, phagocytosis, and wound repair [32]. Moreover, 
fibronectin was reported to be involved in astroglial pro-
liferation. Previous study revealed that astrocytes play a 
major role in the regulation of the immune/inflamma-
tory response in several human central nervous system 
diseases [33, 34]. In epilepsy-associated pathologies, 
astrocytes in tissues of patients with epilepsy undergo 
significant changes in their physiological properties 
[35]. As a result, we can predict that FN1 may be a can-
didate molecular marker associated with the occurrence 
and progression of epilepsy patients by affecting the 
astrocytes.
In conclusion, our study provided a comprehensive 
bioinformatics analysis of DEGs and functions which 
may be involved in the progression of epilepsy. Immune 
response, complement system and sodium ion transport 
may play major roles in the pathogenesis of epilepsy. The 
dysregulation of C1QB, C1S, CFI, SCN3B and FN1 may 
be used potential gene targets for epilepsy treatment. 
Although there are some novel findings, a lack of experi-
mental evidences is a limitation in our study. Further 
experimental studies should be conducted to validate our 
findings in the future.
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